News|Articles|December 13, 2023
Harnessing cell line engineering capabilities to enhance biotherapeutic products
Author(s)Revvity
Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
4
Pharmaceutical Supply Chain Resilience in a Shifting Market
5